Stronghold Plus

RSS

selamectin / sarolaner

Authorised
This medicine is authorised for use in the European Union.

Overview

This is a summary of the European public assessment report (EPAR) for Stronghold Plus. It explains how the Agency assessed this veterinary medicine to recommend its authorisation in the European Union (EU) and its conditions of use. It is not intended to provide practical advice on how to use Stronghold Plus.

For practical information about using Stronghold Plus, animal owners or keepers should read the package leaflet or contact their veterinarian or pharmacist.

This EPAR was last updated on 05/11/2018

Authorisation details

Product details
Name
Stronghold Plus
Agency product number
EMEA/V/C/004194
Active substance
  • selamectin
  • sarolaner
International non-proprietary name (INN) or common name
selamectin / sarolaner
Species
Cats
Anatomical therapeutic chemical veterinary (ATCvet) codes
QP54AA55
Publication details
Marketing-authorisation holder
Zoetis Belgium SA
Revision
2
Date of issue of marketing authorisation valid throughout the European Union
08/02/2017
Contact address

Rue Laid Burniat 1
1348 Louvain-la-Neuve
Belgium

Product information

25/10/2018 Stronghold Plus - EMEA/V/C/004194 - IG/0976 (0004)

Contents

Please note that the size of the above document can exceed 50 pages.

You are therefore advised to be selective about which sections or pages you wish to print.

Pharmacotherapeutic group

  • Antiparasitic products
  • insecticides and repellents
  • Macrocyclic lactones

  • combinations

Therapeutic indication

For cats with, or at risk from, mixed parasitic infestations by ticks and fleas, lice, mites, gastrointestinal nematodes or heartworm.

The veterinary medicinal product is exclusively indicated when use against ticks and one or more of the other target parasites is indicated at the same time.

Assessment history

How useful was this page?

Add your rating
Average
1 rating
1 rating